◆ TICKERBASE · US STOCK FINANCIAL DATA LIBRARY

HomeAll stocks › MDLN

Medline Inc. Class A Common Stock (MDLN) Financial History

20 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES · DATA UPDATED 2026-07-19

Medline Inc. Class A Common Stock (MDLN) operates in the MEDICAL INSTRUMENTS & SUPPLIES industry and is headquartered in Northfield, United States with about 45,000 employees. Its market capitalization is roughly $69 billion. In the fiscal year ended 2025-12-31, MDLN reported $28.4B in revenue and $1.2B in net income.

Medline Inc. manufactures med-surg products serving the hospital, surgery centers, physician offices, post-acute facilities, and nursing home sites of care in the United States and Internationally. It operates through two segments: Medline Brand and Supply Chain Solutions.

Interactive charts & full statements → Open the MDLN valuation workbench →

MDLN Revenue & Earnings History — Annual Income Statement

Income statementTTM → 2026-03-312025-12-312024-12-312023-12-312022-12-31
Total Revenue$29.1B$28.4B$25.5B$23.2B$21.4B
Gross Profit$7.0B$7.5B$6.3B$5.2B$4.6B
Gross Margin %24.0%26.4%24.7%22.5%21.2%
Operating Income (EBIT)$2.0B$2.2B$2.2B$1.4B$870M
Operating Margin %7.0%7.8%8.7%6.2%4.1%
Net Income$964M$1.2B$1.2B$234M($25M)
Net Margin %3.3%4.1%4.7%1.0%-0.1%
EBITDA$2.7B$2.0B$3.5B$2.6B$1.9B
Earnings Per Share (EPS)$1.21$1.43$1.52$0.30$-0.03
Shares Outstanding (M)825M812M787M787M787M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

MDLN Quarterly Revenue & Earnings — Last 8 Quarters

Quarterly income statement2026-03-312025-12-312025-09-302025-06-302025-03-312024-09-302024-06-30
Total Revenue$7.4B$7.8B$7.1B$6.9B$6.6B$6.4B$6.2B
Gross Profit$1.7B$1.9B$1.7B$1.7B$1.6B$1.6B$1.5B
Gross Margin %22.7%24.6%23.9%25.1%24.8%24.8%24.2%
Operating Income (EBIT)$422M$425M$574M$629M$591M$574M$516M
Operating Margin %5.7%5.5%8.1%9.1%8.9%9.0%8.3%
Net Income$129M$180M$322M$333M$322M$324M$292M
Net Margin %1.8%2.3%4.5%4.8%4.9%5.1%4.7%
EBITDA$681M$382M$826M$842M$799M$760M$806M
Earnings Per Share (EPS)$0.16$0.22$0.41$0.42$0.40$0.41$0.37
Shares Outstanding (M)825M812M787M787M800M787M787M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

MDLN Free Cash Flow History

Cash flowTTM → 2026-03-312025-12-312024-12-312023-12-312022-12-31
Cash from Operations (CFO)$1.5B$1.7B$1.8B$1.7B$187M
Capital Expenditures (CapEx)$679M$447M$364M$285M$254M
Free Cash Flow (FCF)$841M$1.3B$1.4B$1.4B($67M)
FCF Margin %2.9%4.6%5.5%6.0%-0.3%
Dividends Paid$96M$518M$114M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

MDLN Quarterly Free Cash Flow — Last 8 Quarters

Quarterly cash flow2026-03-312025-12-312025-09-302025-06-302025-03-312024-09-30
Cash from Operations (CFO)$412M$229M$636M$243M$636M$722M
Capital Expenditures (CapEx)$96M$342M$101M$140M$101M$107M
Free Cash Flow (FCF)$316M($113M)$535M$103M$535M$615M
FCF Margin %4.3%-1.5%7.5%1.5%8.1%9.6%
Dividends Paid$96M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

MDLN Balance Sheet History

Balance sheet2026-03-312025-12-312024-12-312023-12-31
Total Assets$39.0B$38.5B$36.0B$36.1B
Cash & Cash Equivalents$2.2B$1.9B$250M$1.6B
Total Liabilities$19.7B$19.2B$19.5B$19.1B
Total Debt (Short + Long-Term)$12.6B$12.6B$154M$122M
Total Shareholders' Equity$11.3B$10.7B$16.5B$17.0B

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive MDLN viewer.

← MDIAAll stocksMDLZ →

About TickerBase · Data methodology & sources

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.